{"title":"Liquid and Synthetic Biopsies Are Poised to Rewrite Cancer Care.","authors":"Mary Bates","doi":"10.1109/MPULS.2025.3640838","DOIUrl":null,"url":null,"abstract":"<p><p>Liquid biopsy is an innovative and promising alternative to traditional tissue biopsy for detecting and monitoring cancer. It involves analyzing cancer-related biomarkers, such as genetic material shed from tumors, in the blood or other body fluids. Synthetic biopsy is a related approach in which cancer cells are forced to produce biomarkers that reveal their presence. Liquid biopsy tests have been used for years to identify actionable genetic mutations that respond to certain targeted cancer therapies. Researchers are now working to integrate liquid and synthetic biopsies into other facets of cancer care, including screening and early detection, tracking disease progression, monitoring therapeutic response, and assessing minimal residual disease (MRD).</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"16 6","pages":"22-25"},"PeriodicalIF":1.2000,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IEEE Pulse","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1109/MPULS.2025.3640838","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Liquid biopsy is an innovative and promising alternative to traditional tissue biopsy for detecting and monitoring cancer. It involves analyzing cancer-related biomarkers, such as genetic material shed from tumors, in the blood or other body fluids. Synthetic biopsy is a related approach in which cancer cells are forced to produce biomarkers that reveal their presence. Liquid biopsy tests have been used for years to identify actionable genetic mutations that respond to certain targeted cancer therapies. Researchers are now working to integrate liquid and synthetic biopsies into other facets of cancer care, including screening and early detection, tracking disease progression, monitoring therapeutic response, and assessing minimal residual disease (MRD).
期刊介绍：
IEEE Pulse covers both general and technical articles on current technologies and methods used in biomedical and clinical engineering; societal implications of medical technologies; current news items; book reviews; patent descriptions; and correspondence. Special interest departments, students, law, clinical engineering, ethics, new products, society news, historical features and government.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
